[1] Sedaghat S, Sedaghat M, Krohn S, et al.Long-term diagnostic value of MRI in detecting recurrent aggressive fibromatosis at two multidisciplinary sarcoma centers[J]. Eur J Radiol, 2021, 134: 109406. [2] Tamaki I, Takahara H.Metachronous Sporadic Desmoid Tumors Arisen in the Stomach and the Cecum[J]. Cureus, 2021, 13(5): e14847. [3] Penel N, Coindre JM, Bonvalot S, et al.Management of desmoid tumours: A nationwide survey of labelled reference centre networks in France[J]. Eur J Cancer, 2016, 58: 90-96. [4] Eastley N, Aujla R, Silk R, et al.Extra-abdominal desmoid fibromatosis--a sarcoma unit review of practice, long term recurrence rates and survival[J]. Eur J Surg Oncol, 2014, 40(9): 1125-1130. [5] Garcia-Ortega DY, Martín-Tellez KS, Cuellar-Hubbe M, et al.Desmoid-Type Fibromatosis[J]. Cancers, 2020, 12(7): 1851. [6] 高志翔, 周旭峰, 何莎莎, 等.腹壁韧带样型纤维瘤病CT和MR表现及病理分析[J]. 中国CT和MRI杂志, 2018, 16(2): 44-47. [7] Wang K, Zhang J, Dong M.Clinical features and long-term outcomes of aggressive fibromatosis of the abdominal wall after surgical resection: A retrospective study and literature review[J]. Asia Pac J Clin Oncol, 2022, 18(1):127-132. [8] Howard JH, Pollock RE.Intra-Abdominal and Abdominal Wall Desmoid Fibromatosis[J]. Oncol Ther, 2016, 4(1): 57-72. [9] 宋致成, 杨建军, 顾岩. 腹腔镜下腹壁侵袭性纤维瘤的R0切除与一期腹壁重建[J]. 中华胃肠外科杂志, 2018, 21(11): 1260. [10] Sumimoto S, Inoue A, Kagawa Y, et al.Intra-abdominal desmoid-type fibromatosis successfully resected using laparoscopic fluorescence imaging with indocyanine green after intersphincteric resection for rectal cancer[J]. Asian J Endosc Surg, 2022, 15(1): 192-196. [11] Vitellaro M, Sala P, Signoroni S, et al.Risk of desmoid tumours after open and laparoscopic colectomy in patients with familial adenomatous polyposis[J]. Br J Surg, 2014, 101(5): 558-565. [12] Meshikhes AW, Al-Zahrani H, Ewies T.Laparoscopic excision of abdominal wall desmoid tumor[J]. Asian J Endosc Surg, 2016, 9(1): 79-82. [13] Desmoid Tumor Working G. The management of desmoid tumours: A joint global consensus-based guideline approach for adult and paediatric patients[J]. Eur J Cancer, 2020, 127: 96-107. [14] Kasper B, Baumgarten C, Garcia J, et al.An update on the management of sporadic desmoid-type fibromatosis: a European Consensus Initiative between Sarcoma PAtients EuroNet (SPAEN) and European Organization for Research and Treatment of Cancer (EORTC)/Soft Tissue and Bone Sarcoma Group (STBSG)[J]. Ann Oncol, 2017, 28(10): 2399-2408. [15] Schut AW, Vriends ALM, Sacchetti A, et al.In desmoid-type fibromatosis cells sorafenib induces ferroptosis and apoptosis, which are enhanced by autophagy inhibition[J]. Eur J Surg Oncol, 2022. doi:10.1016/j.ejso.2022.02.020.[Epub ahead of print] [16] Gounder MM, Mahoney MR, Van Tine BA, et al.Sorafenib for Advanced and Refractory Desmoid Tumors[J]. N Engl J Med, 2018, 379(25): 2417-2428. |